GSK vs KW · P/E 13, $103.31B cap vs P/E 91, rev $531.4M
GlaxoSmithKline PLC ADR (GSK) versus Kennedy-Wilson Holdings Inc (KW) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Kennedy-Wilson Holdings Inc (KW) is a real estate services company listed on NYSE.
GSK does not have a complete income-statement cache yet.
Latest reported KW revenue for 2024-12-31 was $531.4M. Net income was -$33.7M. Revenue was down 5.5% from 2023-12-31 to 2024-12-31. KW currently screens at market cap $1.52B and trailing P/E 91.0.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. KW currently screens at market cap $1.52B and trailing P/E 91.0.
Not investment advice. Open the GSK and KW stock pages for the full models.
Not investment advice.